Personal profile
Headline
PROFESSOR Medicine, Cardiology
Fingerprint
Dive into the research topics where Juan Badimon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Correction to: “Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction”
Santos-Gallego, C. G., Requena-Ibáñez, J. A., Picatoste, B., Fardman, B., Ishikawa, K., Mazurek, R., Pieper, M., Sartori, S., Rodriguez-Capitán, J., Fuster, V. & Badimon, J. J., Jan 2026, In: Circulation: Cardiovascular Imaging. 19, 1, e000090.Research output: Contribution to journal › Comment/debate
-
Sotagliflozin: Two Birds with One Stone?
Requena-Ibáñez, J. A., Kindberg, K. M., Santos-Gallego, C. G., Zafar, M. U. & Badimon, J. J., Apr 2026, In: Cardiovascular Drugs and Therapy. 40, 2, p. 671-679 9 p.Research output: Contribution to journal › Review article › peer-review
4 Scopus citations -
Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies
Alam, U., Mathai, S. V., Filtz, A., Kuno, T., Badimon, J. J., Sniderman, A. D., Virani, S. S., Toth, P. P., Shapiro, M. D., Lavie, C. J., Bhatt, D. L. & Slipczuk, L., Dec 2026, In: Current Cardiology Reports. 28, 1, 8.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: The EMPATROPISM-FE trial
Angermann, C. E., Sehner, S., Gerhardt, L. M. S., Santos-Gallego, C. G., Requena-Ibanez, J. A., Zeller, T., Maack, C., Sanz, J., Frantz, S., Ertl, G. & Badimon, J. J., 21 Apr 2025, In: European Heart Journal. 46, 16, p. 1507-1523 17 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
Are Sodium-Glucose Cotransporter-2 Inhibitors the Cherry on Top of Cardio-Oncology Care?
Gongora, C. A., Zhang, L., Mattei, J. L., Ruiz-Mori, E., Gonzalez-Robledo, G., Slipczuk, L., Lara, J., Cossio-Aranda, J. E. & Badimon, J., Aug 2025, In: Cardiovascular Drugs and Therapy. 39, 4, p. 849-856 8 p.Research output: Contribution to journal › Review article › peer-review
6 Scopus citations
Press/Media
-
Lexicon Updates on 3 Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo
24/03/26 → 30/03/26
10 items of Media coverage
Press/Media
-
Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo
24/03/26
1 item of Media coverage
Press/Media
-
Lexicon Pharmaceuticals retreats 7.4% in Week 11 of 2026: Latest News and Company Communication
23/03/26
1 item of Media coverage
Press/Media
-
Lexicon Pharmaceuticals ticks down 1.2% in Week 10 of 2026: Latest News and Company Communication
16/03/26
1 item of Media coverage
Press/Media